Product Images Valsartan And Hydrochlorothiazide
View Photos of Packaging, Labels & Appearance
- Label Image - lbl500901762
- lbl500901763
- Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1
- Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2
- Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3
- Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4
- Chemical Structure1 - valhyctz str1
- Chemical Structure 2 - valhyctz str2
Product Label Images
The following 8 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 50090-1763 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl500901762
The text appears to be partially readable and partially gibberish. The readable part of the text suggests that the item being described should be stored at a temperature between 68 and 77 degrees Fahrenheit and mentions "9 tasters." However, the rest of the text appears to be non-English characters and gibberish. Therefore, it is not possible to generate a useful description based on this result.*
lbl500901763
Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1
The text describes a medical study evaluating the effectiveness of the medication Valsartan and Hydrochlorothiazide in reducing systolic blood pressure. The study tracked baseline blood pressure levels of participants and measured the probability of achieving a systolic blood pressure of less than 140 mmHg at week 8 using a graph. Details about the medication dosages are also provided.*
Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2
The text describes a figure showing the probability of achieving a diastolic blood pressure (DBP) of less than 90 mmHg at week 8. The figure displays a baseline DBP and measurements of 100, 95, and 105 mmHg.*
Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3
The text describes a figure showing the probability of achieving a systolic blood pressure of less than 130 mmHg at Week 8 using Valsartan and Hydrochlorothiazide medication. The figure displays the baseline SBP readings between 140 to 180 mmHg. There are three types of medication compared in the figure- Valsartan and Hydrochlorothiazide at doses 320mg/25mg and 284mg and a Placebo.*
Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4
This is a graph that shows the probability of achieving diastolic blood pressure below 80mmHg after 8 weeks of treatment with Valsartan and Hydrochlorothiazide, compared to a placebo, in patients with a baseline blood pressure above 95-110 mmHg. The dosage of Valsartan is 320mg and Hydrochlorothiazide is 25mg.*
Chemical Structure1 - valhyctz str1
Chemical Structure 2 - valhyctz str2
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
